Accuray (ARAY) FCF Margin (2010 - 2026)
Accuray posted quarterly FCF Margin of 0.99% for Q1 2026, down 949.0% year-on-year from 0.12% in Q1 2025, and up 95.0% on a QoQ basis from 19.91% in Q4 2025.
Accuray (ARAY) has 17 years of FCF Margin data on file, last reported at 0.99% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 949.0% year-over-year to 0.99%; the trailing twelve-month figure through Mar 2026 stood at 3.05% (down 365.0% YoY), and the FY2025 full-year result was 0.43%, up 320.0% from the prior year.
- FCF Margin for Q1 2026 stood at 0.99%, up from 19.91% in the prior quarter.
- Across five years, FCF Margin topped out at 12.37% in Q3 2025 and bottomed at 40.01% in Q3 2023.
- The 5-year median for FCF Margin is 1.12% (2022), against an average of 7.57%.
- Peak annual rise in FCF Margin reached 12367 bps in 2022, while the deepest fall reached 4326 bps in 2022.
- A 5-year view of FCF Margin shows it stood at 15.91% in 2022, then soared by 32 bps to 10.87% in 2023, then surged by 102 bps to 0.21% in 2024, then plunged by 9463 bps to 19.91% in 2025, then soared by 95 bps to 0.99% in 2026.
- The last three FCF Margin figures came in at 0.99% (Q1 2026), 19.91% (Q4 2025), and 12.37% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn | -0.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.99% |
| Dec 31, 2025 | -19.91% |
| Sep 30, 2025 | 12.37% |
| Mar 31, 2025 | 8.49% |
| Dec 31, 2024 | 0.21% |
| Sep 30, 2024 | -7.62% |
| Mar 31, 2024 | -24.64% |
| Dec 31, 2023 | -10.87% |
| Sep 30, 2023 | -40.01% |
| Mar 31, 2023 | 1.76% |
| Dec 31, 2022 | -15.91% |
| Sep 30, 2022 | -0.13% |
| Mar 31, 2022 | -1.12% |
| Dec 31, 2021 | 27.36% |
| Sep 30, 2021 | -123.80% |
| Mar 31, 2021 | 30.12% |
| Dec 31, 2020 | 19.17% |
| Sep 30, 2020 | -4.03% |
| Jun 30, 2020 | 545.24% |
| Mar 31, 2020 | -12.41% |
| Dec 31, 2019 | 15.37% |
| Sep 30, 2019 | -28.90% |
| Jun 30, 2019 | 6.82% |
| Mar 31, 2019 | -7.89% |
| Dec 31, 2018 | -14.06% |
| Sep 30, 2018 | -20.27% |
| Jun 30, 2018 | 28.20% |
| Mar 31, 2018 | 1.57% |
| Dec 31, 2017 | -1.76% |
| Sep 30, 2017 | -15.34% |
| Jun 30, 2017 | 19.38% |
| Mar 31, 2017 | -13.34% |
| Dec 31, 2016 | -6.97% |
| Sep 30, 2016 | -9.32% |
| Jun 30, 2016 | 18.58% |
| Mar 31, 2016 | -10.40% |
| Dec 31, 2015 | 5.00% |
| Sep 30, 2015 | 11.95% |
| Jun 30, 2015 | 3.42% |
| Mar 31, 2015 | -1.41% |
| Dec 31, 2014 | 0.26% |
| Sep 30, 2014 | -21.13% |
| Jun 30, 2014 | 7.83% |
| Mar 31, 2014 | 11.35% |
| Dec 31, 2013 | -5.71% |
| Sep 30, 2013 | -18.87% |
| Jun 30, 2013 | 8.27% |
| Mar 31, 2013 | -31.96% |
| Dec 31, 2012 | -41.83% |
| Sep 30, 2012 | -22.33% |
| Jun 30, 2012 | -8.50% |
| Mar 31, 2012 | 1.78% |
| Dec 31, 2011 | 7.51% |
| Sep 30, 2011 | -50.09% |
| Jun 30, 2011 | 193.97% |
| Mar 31, 2011 | -18.48% |
| Dec 31, 2010 | 15.75% |
| Sep 30, 2010 | -30.42% |